Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Revenova is a provider of CRM-powered transportation management systems (TMS) for 3PLs, Freight Brokers, Carriers and Shippers
Arcaea's mission is to build a new foundation for the beauty industry through expressive biology.
Patina is reinventing primary care for adults 65+ so everyone gets the healthcare and aging experience they deserve.
Astarte Medical is clinical intelligence company providing digital solutions to support protocol-driven care across pediatric populations.
Resilient Biotics utilizes big data analytics to design microbiome-based therapeutics and advanced screening methods.
A health tech company disrupting how those struggling to conceive access specialty fertility care through the best of science and tech.
A joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants.
The world's First and Only Personalization Platform for Health and Wellness Products and Services Tailored to Your DNA and Lifestyle.
Viking Global Investors has invested in 56 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Viking Global Investors's top investment sectors include Health Care, Biotechnology, Analytics, Wellness, Cloud Computing. The firm invests across 31 different industry categories.
Among tracked funding rounds, Joyn Bio received $100.0M in a Series A round. Viking Global Investors's total known invested capital is $3.0B.
Viking Global Investors's average investment size is $53.4M across its portfolio of 56 companies.
Recent Viking Global Investors portfolio additions include Revenova, Arcaea, Patina, Astarte Medical, Resilient Biotics. These companies were founded in 2020 or later.